PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33922328-0	2021	In Vitro Enzymatic and Kinetic Studies, and In Silico Drug-Receptor Interactions, and Drug-Like Profiling of the 5-Styrylbenzamide Derivatives as Potential Cholinesterase and beta-Secretase Inhibitors with Antioxidant Properties.	5-styrylbenzamide	113-130	acetylcholinesterase (Cartwright blood group)	Homo sapiens	156-170	
33922328-2	2021	These 5-styrylbenzamide derivatives were evaluated through enzymatic assays in vitro for their capability to inhibit acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and beta-secretase (BACE-1) activities as well as for antioxidant potential.	5-styrylbenzamide	6-23	acetylcholinesterase (Cartwright blood group)	Homo sapiens	117-137	
33922328-2	2021	These 5-styrylbenzamide derivatives were evaluated through enzymatic assays in vitro for their capability to inhibit acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and beta-secretase (BACE-1) activities as well as for antioxidant potential.	5-styrylbenzamide	6-23	acetylcholinesterase (Cartwright blood group)	Homo sapiens	139-143